The revolving door turns again.
After a two-year stint running the Food and Drug Administration, Scott Gottlieb has joined the board of directors at Pfizer, giving the world’s largest drug maker crucial insights into the inner workings of the Trump administration as it attempts to contain national angst over the rising cost of medicines.
And in doing so, Gottlieb is also picking up where he left before joining the agency, since he had been on the board of several smaller pharmaceutical companies and was also a partner at a venture capital firm that invests in life sciences companies.
About the Author Reprints
Is there any chance that there’s a connection between Mr. Gottlieb’s crusade to outlaw and demonize kratom during his time at the FDA and his strong ties to the pharmaceutical industry?
Having ethics and a conscience would be nice.
What’s a pharma whore supposed to do?